key: cord-0784400-e63740r1 authors: Jain, Ruchi; Ramaswamy, Sathishkumar; Harilal, Divinlal; Uddin, Mohammed; Loney, Tom; Nowotny, Norbert; Alsuwaidi, Hanan; Varghese, Rupa; Deesi, Zulfa; Alkhajeh, Abdulmajeed; Khansaheb, Hamda; Alsheikh-Ali, Alawi; Tayoun, Ahmad Abou title: Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes date: 2020-09-28 journal: bioRxiv DOI: 10.1101/2020.09.28.316604 sha: 55f36fe8901ca7ea1197b58fabebb0c7c37e1737 doc_id: 784400 cord_uid: e63740r1 Characterizing key molecular and cellular pathways involved in COVID-19 is essential for disease prognosis and management. We perform shotgun transcriptome sequencing of human RNA obtained from nasopharyngeal swabs of patients with COVID-19, and identify a molecular signature associated with disease severity. Specifically, we identify globally dysregulated immune related pathways, such as cytokine-cytokine receptor signaling, complement and coagulation cascades, JAK-STAT, and TGF-β signaling pathways in all, though to a higher extent in patients with severe symptoms. The excessive release of cytokines and chemokines such as CCL2, CCL22, CXCL9 and CXCL12 and certain interferons and interleukins related genes like IFIH1, IFI44, IFIT1 and IL10 were significantly higher in patients with severe clinical presentation compared to mild and moderate presentations. Moreover, early induction of the TGF-β signaling pathway might be the primary cause of pulmonary fibrosis in patients with severe disease. Differential gene expression analysis identified a small set of regulatory genes that might act as strong predictors of patient outcome. Our data suggest that rapid transcriptome analysis of nasopharyngeal swabs can be a powerful approach to quantify host molecular response and may provide valuable insights into COVID-19 pathophysiology. Since the first case reported in December 2019 in Wuhan, SARS-CoV-2 has spread very quickly across 188 different countries leading to over 31,887,485 COVID-19 cases and 976,789 associated deaths worldwide as of 24 th September 2020. 1 The common signs and symptoms of SARS-CoV-2 include fever, cough, fatigue, shortness of breath, and chest CT abnormalities. 2 Some patients with COVID-19 quickly develop severe pulmonary symptoms including acute respiratory distress syndrome (ARDS), pulmonary edema, intense kidney injury and multiple organ failure 3 whereas other patients present with no symptoms or with only mild disease. 4 Pathogen load and prevalence of infections are higher in males than females demonstrating that sex physiology plays a role in infectious disease pathogenesis. 5 Meng and colleagues 6 showed that men who died of COVID-19 had elevated levels of systemic inflammatory markers such as neutrophil-to-lymphocyte ratio and C-reactive protein. Nevertheless, the mechanism behind increased mortality among older adults and males with COVID-19 remains speculative. Despite the worldwide spreading, the host immune response against SARS-CoV-2 infection remains poorly characterized. Dysregulation of host immune response and activation of inflammatory cytokines, known as the "cytokine storm", is associated with disease severity and poor prognosis. 7, 8, 9 A recent host transcriptome study on patients with COVID-19 revealed distinct host inflammatory cytokine profiles and highlighted the association between SARS-CoV-2 pathogenesis and excessive release of cytokine such as CCL2/MCP-1, CXCL10/IP-10, CCL3/MIP-1A, and CCL4/MIP1B. 10 Table 1 ). The sequencing read quality was checked using FastQC v0.11.8 15 The number of reads mapped to each gene in the genome (GRCh37) was calculated using the FeatureCounts program in the SubReads package v2.0.1. 19 DESeq2 package v1.28.1 20 was applied to perform batch effects and normalization. In brief, DESeq2 uses the median of ratios method to normalize data and estimate size factors (which control for differences in the library size of the sequencing experiment). Further, gene expression change was calculated with respect to control for each groups using Wald test and p-values and log 2 fold change was extracted. The resulting genes p-value was adjusted using the Benjamini and Hochberg method. These adjusted p-value (adj p-value) are calculated as: where m is the total number of genes, i is the gene p-value rank. Here we have considered a fraction of 5% false positives acceptable hence the genes with adj p-value < 0.05 were called as significant. Pathway enrichment analysis was performed using the clusterProfiler package v 3.16.0 21 to identify shared pathways among DEGs. Pathways with adj p-value < 0.05 were reported as significant. Heatmaps were generated using Morpheus 22 and volcano plots were generated using VolcaNoseR package. 23 Both case and control sequencing data were normalized to counts per million (CPM), which is calculated by normalizing the read counts for a given gene by the total counts per sample. CPM values were used to compare expression between certain genes and violin plots were generated using GraphPad Prism v8.0. 24 Two tailed Mann-Whitney U test P-values are reported. A schematic illustration of data analysis is represented in Figure 1 . Our patient cohort consisted of fifty patients with COVID-19 (36% female) who tested positive for SARS-CoV-2 by RT-qPCR with a mean age of 40.9 years (ranging from 3 -70 years) at diagnosis. Cases were categorized into mild, moderate, and severe as previously described. 12 (Figure 2) . Figure 1) . Furthermore, pathway enrichment analysis showed modulation, to varying extents (Figure 3 ), of several overlapping pathways among mildly, moderately, and severely affected patients (Supplementary Figure 1) . In addition to upregulation of immune-related response genes, there was consistent disruption of the ribosome pathway. The SARS-CoV-2 receptor ACE2 is an interferon-regulated gene and is upregulated in response to SARS-CoV-2 infection. 25 We also found that ACE2 expression was highest in patients with severe disease compared to patients with mild and moderate disease (Figure 3 ). To further delineate the differences among these groups, we compared the expression levels of genes and associated pathways (complement and coagulation cascades, cytokine-cytokine receptor interaction, JAK STAT signaling, TGF beta signaling pathway, platelets activation and ribosome pathway) between patients with mild, moderate, and severe disease. Gene expression in most regulated pathways was significantly higher (adj p-value < 0.05) in patients with severe disease compared to those with mild or moderate disease (Figure 3) . Our RNA work, using nasopharyngeal tissue, extends those findings to show that those pathways are more significantly altered in patients with severe disease outcomes. Specifically, SARS-CoV-2 seems to induce expression of certain genes (Figure 4) to higher extents in patients with severe, compared to those with mild or moderate disease. This finding has direct prognostic and therapeutic implications. Identifying molecules targeting the pathways where those genes are involved might help ameliorate or avoid adverse clinical outcomes due to SARS-CoV-2. Moreover, this early expression signature can be used to predict the clinical course of disease, so that required early interventions can be implemented. However, larger datasets are needed to validate this expression signature and to show that it can reliably predict disease outcomes in the general population. Certain molecular pathways require specific attention. In the majority of patients with COVID-19, respiratory failure is the primary cause of death and is often associated with uncontrolled inflammatory responses, edema, and lung fibrosis. 30 This lung fibrosis is mainly triggered by transforming growth factor-beta (TGF-β). 10 In our analysis, the TGF-β pathway was significantly upregulated in patients with severe disease suggesting they are more prone to respiratory failure. The PI3K/Akt and JAK/STAT signaling pathways are two other noteworthy pathways given that several cellular and immune responses, including host cell immune response to counteract viral infection 31 , activation of interferon-stimulated genes (ISGs) 32 , and activation of several regulatory and pro-inflammatory cytokines 33 converge on those two pathways. Our gender-specific transcriptomic analysis revealed a few genes which were upregulated in male patients compared to females (Figure 5 ). It is highly likely that many other key factors, which are involved in sex-specific responses to SARS-CoV-2, were not detected in our study. It is possible that our cohort was not large enough to perform appropriate comparisons on a large number of patients adequately stratified for age, sex, and disease severity. Taken together, our study highlights key molecular and functional pathways involved in COVID-19 pathogenesis and characterizes a specific early expression signature associated with severe disease outcomes due to SARS-CoV-2. in patient with mild (c), moderate (d), and severe (e) outcomes. X-axis represents log 2 fold change of genes and y axis represents -log 10 P-value in DEG analysis. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020 China Medical Treatment Expert Group for C: Clinical Characteristics of Coronavirus Disease 2019 in China Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions SeXX Matters in Infectious Disease Pathogenesis Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus The host immune response in respiratory virus infection: balancing virus clearance and immunopathology SARS and MERS: recent insights into emerging coronaviruses Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients In vivo antiviral host response to SARS-CoV-2 by viral load, sex, and age Genomic surveillance and phylogenetic analysis reveal multiple introductions of SARS-CoV-2 into a global travel hub in the Middle East SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region FastQC: a quality control tool for high throughput sequence data MultiQC: summarize analysis results for multiple tools and samples in a single report HISAT: a fast spliced aligner with low memory requirements featureCounts: an efficient general purpose program for assigning sequence reads to genomic features Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 clusterProfiler: an R package for comparing biological themes among gene clusters VolcaNoseR -a web app for creating, exploring and sharing volcano plots GraphPad Prism version 8.00 for Windows, GraphPad Software Ordovas-Montanes J, lung-network@humancellatlas.org HCALBNEa, Network HCALB: SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions Dysregulation of Immune Response in Patients with Coronavirus Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine Make yourself at home: viral hijacking of the PI3K/Akt signaling pathway The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY Mechanisms of Jak/STAT signaling in immunity and disease